Ned Milenkovich, co-chair of the firm's Health Care practice, moderated a Pharmacy Times program on the pathophysiology and outcomes of Alzheimer's disease (AD). Panelists discussed disease-modifying treatments for AD and how managed care organizations can successfully integrate these therapies as part of patients' disease management plans.
The program is available on the Pharmacy Times Continuing Education website. It is approved for 1.5 contact hours under the ACPE Universal Activity Number 0290-0000-18-228-H01-P. The activity is available until November 30, 2019.